Results 101 to 110 of about 582,334 (336)

Towards an individualized management strategy for patients with chronic venous disease: Results of a Delphi consensus [PDF]

open access: yes, 2017
Objective: To obtain consensus on management criteria for symptomatic patients with chronic venous disease (CVD; C2–C6) and superficial venous reflux.
Bos, R.R. (Renate) van den   +4 more
core   +1 more source

Liver molecular networks associated with drinking behavior in nonhuman primates

open access: yesAlcohol, Clinical and Experimental Research, EarlyView.
We identified hepatic molecular networks that differed between light drinkers (LD) and very heavy drinkers (VHD) before they were exposed to alcohol, as well as epigenetic differences between LD and VHD in response to the same amount of alcohol.
Laura A. Cox   +11 more
wiley   +1 more source

Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients

open access: yesWorld Journal of Surgical Oncology, 2017
Background Inguinal lymph node dissection (LND) is a surgical procedure with a high morbidity rate. Variations in surgical procedure, such as sparing of the saphenous vein, have been proposed to reduce surgical morbidity.
Johannes Baur   +7 more
doaj   +1 more source

Development of an assessment tool for ultrasound‐guided regional anaesthesia image interpretation

open access: yesAnaesthesia, EarlyView.
Summary Introduction The success of ultrasound‐guided regional anaesthesia depends on the acquisition and interpretation of optimal ultrasound images. This study aimed to develop an assessment tool to evaluate proficiency in interpreting ultrasound images for regional anaesthesia.
Sam J. Haddad   +24 more
wiley   +1 more source

Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway [PDF]

open access: yes, 2017
Objective: Pulsatile forces regulate vascular remodeling and trigger vascular diseases such as saphenous vein graft disease. The saphenous vein is exposed to high pressure and pulsatility only after implantation.
Eto, Masato   +4 more
core  

Interventional varicose vein therapy using endoluminal laser ablation (1940 nm) in patients with Ehlers‐Danlos syndromes: two case reports

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary In patients with Ehlers‐Danlos syndrome, the presence of chronic venous insufficiency poses a particular challenge for physicians when determining the indication for surgical treatment. Due to vascular fragility, complications such as vascular tears or ruptures with difficult hemostasis and potentially life‐threatening consequences occur ...
Dennis Braß   +2 more
wiley   +1 more source

The Mirage of Factor Equivalence: Examining the Complexities of Non‐Factor Therapies in Haemophilia

open access: yesHaemophilia, EarlyView.
ABSTRACT Background This article provides a critical analysis of the ‘factor equivalence’ concept as applied to non‐factor therapies (NFTs) for haemophilia, highlighting its limitations and clinical implications. Although factor equivalence estimates serve as a comparative tool for evaluating pro‐coagulant effects across different therapies, they may ...
Yesim Dargaud   +2 more
wiley   +1 more source

Total Stripping of the Great Saphenous Vein in Varicose Vein Patients with Thrombophlebitis

open access: yesКреативная хирургия и онкология
Introduction. Patients with varicose disease of the lower extremities may suffer from subcutaneous vein thrombophlebitis with an incidence of more than 50%.
T. M. Murasov   +4 more
doaj   +1 more source

Endovenous laser ablation therapy in children: applications and outcomes [PDF]

open access: yes, 2017
BACKGROUND: Endovenous laser ablation is well recognized as the first-line treatment for superficial venous reflux with varicose veins in adults. It is not widely reported and is not an established practice in pediatric patients. OBJECTIVE: To illustrate
Amaral, JG   +4 more
core   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Home - About - Disclaimer - Privacy